Office-Wide Innovative Solutions Opening for Health Science Futures (HSF)
ID: ARPA-H-SOL-24-104Type: Solicitation
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFNATIONAL INSTITUTES OF HEALTHNIH ADVANCED RESEARCH PROJECTS AGENCY FOR HEALTH (ARPA-H)Bethesda, MD, 208920004, USA

NAICS

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) (541715)

PSC

HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT (AN13)

Original Source

https://sam.gov/opp/737bbcbfd8d34a1e939670aea686dc67/view
Timeline
    Description

    The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is soliciting proposals for the Innovative Solutions Opening (ISO) aimed at advancing healthcare technologies. This initiative seeks innovative, disease-agnostic research projects that can significantly improve health outcomes, focusing on areas such as maternal and fetal health, genetic therapies, and novel diagnostic tools. The solicitation emphasizes the development of transformative solutions rather than incremental research, with submissions required to follow a two-step process: an initial solution summary followed by a full proposal based on feedback received. Interested parties must submit their solution summaries by March 3, 2029, via the designated ARPA-H portal, and are encouraged to review the detailed submission guidelines outlined in the provided documentation.

    Point(s) of Contact
    SEE DESCRIPTION SECTION
    do_NOT_use_THIS_email_ADDRESS@arpa-h.gov
    Files
    Title
    Posted
    A07_HSF_ISO_Amend_1.pdf
    The Advanced Research Projects Agency for Health (ARPA-H) has announced the Innovative Solutions Opening (ISO) under solicitation number ARPA-H-SOL-24-104, inviting proposals for groundbreaking healthcare technologies. This solicitation aims to support innovative, disease-agnostic research projects that can significantly enhance health outcomes. Key interest areas include breakthrough technologies for maternal and fetal health, genetic and cellular therapies, and novel diagnostic tools. Eligible participants include universities, non-profits, and small businesses, with a deadline for submission set until March 3, 2029. Proposers must initially submit a solution summary for feedback before proceeding with full proposals, which will be evaluated based on scientific merit, relevance to ARPA-H’s mission, and proposer capabilities. The solicitation emphasizes transformative, high-impact solutions over incremental research and excludes proposals for traditional policy changes or infrastructure projects. Awards will primarily include Other Transactions and Cooperative Agreements, allowing for flexibility in negotiation without the constraints of Federal Acquisition Regulation. The process encourages innovative approaches that incorporate open standards and interoperability in healthcare technology.
    Appendix A - Solutions Summary Template.docx
    The ARPA-H solicitation document outlines the requirements for submitting solution summaries in response to government Requests for Proposals (RFPs). It emphasizes the need for clarity and innovation in proposed technology concepts that address high-priority interest areas. Key sections include a Concept Summary where submitters detail their solutions and the problems they address, and Innovation and Impact, where the potential disruptiveness and superiority of the proposal over existing technologies should be demonstrated with measurable metrics. Additionally, the document specifies the Proposed Work section, where deliverables, milestones, and technical approaches must be clearly outlined alongside an analysis of technical challenges and risks. Team Organization and Capabilities highlight the roles of project members, supported by a Basis of Estimate (BOE) detailing financial requirements, work breakdown, and project costs. Submissions are restricted to six pages and must be formatted according to specified guidelines, ensuring readability and organization. This document serves to enhance the clarity and effectiveness of proposals within the context of federal funding opportunities, focusing on innovative solutions in healthcare and related fields.
    Attachments - Bundle of Attachments.zip
    Bundle_of_Attachments-Amend_1.zip
    HSF Open Office Innovative Solutions Opening.pdf
    Similar Opportunities
    Office-Wide Innovative Solutions Opening for Scalable Solutions Office (SSO)
    Buyer not available
    The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is soliciting innovative solutions aimed at enhancing healthcare accessibility, affordability, and scalability. This opportunity invites universities, non-profits, small businesses, and similar entities to submit solution summaries and proposals that address health disparities, improve the distribution of healthcare technologies, and advance biomanufacturing innovations. The solicitation emphasizes the development of scalable technologies and collaborative distribution networks, with a focus on interdisciplinary approaches to revolutionize biomedicine and public health outcomes. Interested parties must submit their solution summaries by March 3, 2029, and can find further details and submission guidelines at https://solutions.arpa-h.gov. For inquiries, questions should be directed to the same website.
    Office-Wide Innovative Solutions Opening for Proactive Health Office (PHO)
    Buyer not available
    The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is soliciting innovative research proposals aimed at enhancing health outcomes via the Proactive Health Office (PHO). The initiative focuses on developing solutions that prioritize disease prevention, early intervention, and scalable wellness-promoting behaviors, moving away from traditional reactive healthcare models. This opportunity is significant for entities capable of delivering transformative health solutions, with proposals evaluated based on scientific merit and relevance, and funding potentially awarded through Other Transactions or Cooperative Agreements. Interested parties must submit a mandatory solution summary by March 3, 2029, and can direct inquiries to the designated contact via the provided submission platforms.
    Office-Wide Innovative Solutions Opening for Resilient Systems Office (RSO)
    Buyer not available
    The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is soliciting innovative solutions aimed at enhancing the resilience of healthcare systems via its Resilient Systems Office (RSO). This opportunity invites submissions from eligible entities, including universities, nonprofits, and small businesses, to address systemic challenges in healthcare and public health by leveraging cutting-edge technologies that improve care quality and availability. The solicitation emphasizes the importance of sociotechnical system innovations and adaptive solutions that enhance the reliability and interoperability of health ecosystems. Interested parties must submit solution summaries for feedback before full proposal submissions, with the solicitation open until March 3, 2029. For further inquiries, submissions should be directed to the designated online platforms, and the primary contact email is provided in the solicitation details.
    Final Innovative Solutions Opening (ISO) ARPA-H Rare Disease AI/ML for Precision Integrated Diagnostics (RAPID)
    Buyer not available
    The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is soliciting proposals for the "Final Innovative Solutions Opening (ISO) ARPA-H Rare Disease AI/ML for Precision Integrated Diagnostics (RAPID)" initiative. This program aims to enhance rare disease diagnostics by leveraging advanced data aggregation and analytic techniques, focusing on underdiagnosed populations and the creation of comprehensive datasets to improve diagnostic support tools. The RAPID initiative is structured into two phases over a proposed 4.5-year period, emphasizing equitable access to diagnostics and collaboration with patient networks to validate diagnostic models. Interested applicants can reach out to the RAPID Email Box at RAPID@ARPA-H.gov for further information, with the solicitation providing a critical funding opportunity for innovators in the field.
    PROactive Solutions for Prolonging Resilience (PROSPR)
    Buyer not available
    The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is soliciting proposals for the PROactive Solutions for Prolonging Resilience (PROSPR) program. This initiative aims to extend the healthspan of Americans by developing interventions that address the underlying causes of age-related health decline, including the establishment of a predictive Intrinsic Capacity score and the repurposing of FDA-approved drugs. The program emphasizes a structured, multidisciplinary approach over a five-year timeline, focusing on key milestones such as in-home assessment technologies and decentralized clinical trials to create innovative preventative care models. Interested proposers are encouraged to reach out to the PROSPR Team at PROSPR@arpa-h.gov for inquiries, and further details can be found at the ARPA-H website. The final solicitation is anticipated to be published at a later date.
    ARPA-H ImagiNg Data EXchange (INDEX)
    Buyer not available
    The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is soliciting proposals for the Imaging Data Exchange (INDEX) program aimed at enhancing access to medical imaging data. The primary objective is to develop a sustainable platform that connects medical imaging data providers with researchers and developers, leveraging artificial intelligence and machine learning to address the shortage of qualified radiologists and improve healthcare outcomes. This initiative is critical for advancing algorithm development and clinical studies by creating a comprehensive repository of diverse imaging datasets, including cancer digital pathology and surgical videos. Interested parties must submit their Solution Summary by January 28, 2025, with the full proposal due by March 27, 2025. For further inquiries, contact the INDEX Team at INDEX@arpa-h.gov.
    Ocular Laboratory for Analysis of Biomarkers (OCULAB)
    Buyer not available
    The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is soliciting proposals for the Ocular Laboratory for Analysis of Biomarkers (OCULAB) initiative. This program aims to develop innovative biosensor technologies for the continuous monitoring of tear biomarkers and AI-driven therapeutic delivery systems, particularly targeting conditions such as dry eye disease (DED). The initiative emphasizes collaboration among commercial entities and academic institutions to enhance diagnostic and treatment capabilities, ultimately striving to improve patient outcomes and healthcare accessibility. Interested parties should contact the OCULAB Team at OCULAB@ARPA-H.gov for further details, with multiple awards anticipated as part of this funding opportunity.
    BARDA DRIVe EZ-BAA (EZBAA - 22-100-SOL-00003)
    Buyer not available
    The Department of Health and Human Services, through the Biomedical Advanced Research and Development Authority (BARDA), is soliciting innovative research proposals under the Easy Broad Agency Announcement (EZ-BAA) BAA-22-100-SOL-00003. The initiative aims to address high-risk biomedical challenges related to emerging infectious diseases and public health emergencies, with specific Areas of Interest (AOIs) including vaccine efficacy enhancement, portable viral diagnostics, and medical countermeasures for acute radiation syndrome. This opportunity is crucial for advancing public health preparedness and fostering innovation in medical technologies. Interested parties must have active registration with SAM.gov and are encouraged to submit abstracts by various deadlines, with the next significant closing date for AOI submissions set for March 15, 2024. For further inquiries, contact Sieaun Marks at DRIVeAcquisitions@hhs.gov.
    FY25 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science
    Buyer not available
    The Department of Health and Human Services, specifically the Food and Drug Administration (FDA), is soliciting proposals through the FY25 Broad Agency Announcement (BAA) aimed at advancing regulatory science and innovation. This opportunity invites organizations, particularly small businesses, to submit research and development proposals that address critical areas such as alternative drug development methods, advanced manufacturing technologies, and predictive toxicology, with a strong emphasis on including diverse populations in research. Proposals must be submitted by February 24, 2025, and will undergo a two-tier evaluation process, with the potential for multiple contracts awarded based on proposal quality and funding availability. Interested parties can contact Ian Weiss at Ian.Weiss@fda.hhs.gov or by phone at 301-796-5728 for further information.
    Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA)
    Buyer not available
    The Department of Health and Human Services, through the Biomedical Advanced Research and Development Authority (BARDA), is soliciting proposals under the Broad Agency Announcement (BAA) BAA-23-100-SOL-00004 for advanced research and development of Medical Countermeasures (MCMs) aimed at addressing public health threats such as chemical, biological, radiological, and nuclear (CBRN) incidents, as well as emerging infectious diseases and pandemic influenza. The initiative seeks to foster public-private partnerships to enhance the development and responsiveness of life-saving MCMs, emphasizing the importance of technological maturity, regulatory compliance, and manufacturing standards in the evaluation process. This opportunity is critical for strengthening national health security and improving preparedness for future public health emergencies, with an open submission period running until September 25, 2028, at 4:30 PM Eastern Time. Interested parties can direct inquiries to BARDA-BAA@hhs.gov for further information.